Company: APXIF
Filing Date: 2025-07-18
Form Type: F-4/A
Source: 0001213900-25-065703
Chunk: 474

Company: APx Acquisition Corp. I
Filing Date: 2025-07-18
Form: F-4/A
Chunk 474
---
 assume the role of Chief Financial Officer and director of the Company. Please see “ Business of APx and Certain Information about APx — Directors and Executive Officers.” Martin Vazquez.Upon the Closing of the Business Combination, Mr. Vazquez will assume the role of Chief Science Officer of the Company. Mr. Vazquez co -foundedHeritas Argentina in 2015 and has been serving as its Chief Science Officer since then, bringing a wealth of experience in biotechnology and leadership to the company. Prior to this, he held the same position at Bioceres from 2011 to 2015. Mr. Vazquez earned his Ph.D. in Molecular Biology and

246 Genomics from the University of Buenos Aires in 1996, and since then has deepened his expertise in next -generationsequencing, bioinformatics, and biotechnology. His career highlights include directing significant research and development projects within the biotech sector, particularly with Conicet since 1999, where he led high -impactconsortia in Argentina and played a pivotal role in fostering innovation as an industry advisor. With certifications in strategic management and entrepreneurship obtained in 2020, Vazquez combines his scientific expertise with business acumen. His academic contributions are substantial, including supervising over ten Ph.D. students and teaching at the University of Buenos Aires, where he shared his knowledge on molecular biology, biotechnology, and genetic engineering for more than 15 years. Mr. Vazquez published more than 80 scientific papers in relevant journals. Fabian Fay.Upon the Closing of the Business Combination, Mr. Fay is expected to serve as director of the Company. Mr. Fay currently serves as the Chief Executive Officer of Parent since its inception in 2021. He has held positions such as director of Grupo Oroño, an Argentinean Health Group, since 2022, member of the Endeavor Argentina Regional Board of Directors from 2015 to 2022, president of the Latin American Association of Private Clinical Laboratories since 2010 and director of Medicina Esencial, a regional health management organization since 2003. He also served as the director of ACLIRES LAB from 2007 to 2011 where he was dedicated to phase 1 clinical trials, director of Sanatorio Parque and the Sanatorio de Niños Lab from 1992 until 2004, director of the Center of Molecular Diagnostics in BioSidus from 1995 to 2001 and director and President of C